Medline MDLN
NASDAQ MDLN
$34.05 -0.64 (-1.84%)
As of: Sep 9, 2026 · 3:59 PM EDT

Medline (MDLN) EBT (2025 - 2026)

Medline's (MDLN) quarterly EBT came in at $235.0 million in Q2 2026, down 34.54% year-over-year from $359.0 million in Q2 2025, and down 19.24% quarter-over-quarter from $291.0 million in Q1 2026.

Analysis

Medline (MDLN) EBT (2025 - 2026) Analysis & Trends

Medline (MDLN) has reported EBT for 2 consecutive years, with $235.0 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, EBT fell 34.54% year-over-year to $235.0 million in Q2 2026; TTM through Jun 2026 was $1.2 billion, a N/A change from a year earlier, with the FY2025 full-year figure at $1.2 billion, changed 0.16% from the prior year.
  • EBT was $235.0 million for Q2 2026 at Medline, down from $291.0 million in the prior quarter.
  • Over five years, EBT peaked at $359.0 million in Q2 2025 and troughed at $235.0 million in Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Becton Dickinson 49.48 Bn 48.62 Bn 2.32 Bn 554.00 Mn
2 Medline 29.24 Bn 26.56 Bn 2.22 Bn 235.00 Mn
3 West Pharmaceutical Services 23.94 Bn 23.51 Bn 329.20 Mn 180.10 Mn
4 Baxter International 12.66 Bn 10.51 Bn 1.03 Bn 158.00 Mn
5 Stevanato Group S.p.A 5.51 Bn 5.40 Bn 100.91 Mn 44.31 Mn
6 Acme United 233.67 Mn 228.63 Mn 26.69 Mn 6.30 Mn
7 Rockwell Medical 31.87 Mn 7.07 Mn 3.24 Mn -1.30 Mn
8 Retractable Technologies 21.39 Mn -18.48 Mn 190,852.00 2.83 Mn
9 United Health Products 9.09 Mn 9.06 Mn - -217,306.00
10 Cuprina Holdings (Cayman) 7.45 Mn 4.33 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 235.00 Mn
Mar 28, 2026 291.00 Mn
Jun 28, 2025 359.00 Mn
Mar 29, 2025 338.00 Mn